MedPath

EUMIC transport study

Conditions
interclinical transport, MICU, critical ill transportation, quality measurement,
Registration Number
NL-OMON27738
Lead Sponsor
Maastricht University Medical Centre+
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
3000
Inclusion Criteria

Adult patients (18 years) which undergo an interclinical transport with indication for a physician supervised transport within the study region (MICU region Maastricht, district of Aachen, City of Aachen, district of Heinsberg and Düren).

Exclusion Criteria

Age < 18 years
Interclinical transport without indication for direct supervision of a physician

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To validate the QUIT EMR score in a prospective multicentre study by comparing three defined levels of transport systems.
Secondary Outcome Measures
NameTimeMethod
a)To analyse if negative transport outcome (measured by QUIT EMR score) influences 24-hour post transport morbidity (measured by SEMROS).<br> b)To detect patients’ characteristics that define the patients’ needs in terms of level of transportation facility.<br>c)To detect predictive outcome parameters concerning 24 hours post transport mortality<br>
© Copyright 2025. All Rights Reserved by MedPath